4 ms·
Some relevant parts of https://en.wikipedia.org/wiki/Carboplatin https://en.wikipedia.org/wiki/Carboplatin > It is on the World Health Organization's List of E
by gus_massa 8y ago
Some relevant parts of https://en.wikipedia.org/wiki/Carboplatin https://en.wikipedia.org/wiki/Carboplatin
> It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
This is discussed in the patent, but not in the submission. Add something about it. I don't know which are the current preferred drugs against cancer.
The patent takes forever to load. I got more luck with https://patentscope.wipo.int/search/en/detail.jsf;jsessionid=FCC09B14C354AEBCB207B511F1A03669.wapp2nB?docId=WO2019012149&tab=PCTDESCRIPTION&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=&recNum=8170&maxRec=73493415 https://patentscope.wipo.int/search/en/detail.jsf;jsessionid... and https://patents.google.com/patent/WO2018134265A1/en https://patents.google.com/patent/WO2018134265A1/en
The language of patents is very very very difficult to read. (It's not your fauls, it's standard patent legalese.)Do you have a link to a research paper with similar content?
<IIUC> This drug block the hydrolysis (destruction) of the ATP in mitochondria of the cancer cells. Usually the mitochondria produce ATP, but in this cancer cells the activity of the mitochondria is too low. The mitochondria also produce other useful molecules like NADPH while producing ATP. And if part of the APT is not destroyed, they can't produce the other useful molecules and the cell dies.</IIUC>
How bad is that?
I don't know if you can write a very simplified explanation without breaking the FDA rules or something, but add more information in the site. The graphic of the molecules are always nice. (And the 3D render is even nicer, in spite it's not so useful. Add both.)
- michaelforrest 8y agoCarboplatin is still used very prevalently for many cancers. It is now off patent, and old, but sitll in very common use in developed and developing countries. It is one of the most used cancer drugs. I've led with patents rather than papers because the latter can prevent the former ("prior art"). And no company will take a drug through clinical trials without a patent(s), and it is typically only companies that fund trials (espcially Phase III). So, publishing without patenting, if you actually have something promising, is near on a crime. It effectively renders it forever lost. This isn't actually as well known as it should be amongst researchers. Although most will never get to any point that this is of concern anyhow. RE: the crowdfunding page, thank you for your tips/advice on how to make it better, but today is the last day and as you can see....it is a bust. So, that is that.